Merck held talks to buy Swiss biotech MoonLake for more than $3bn

0
US pharmaceuticals group has been looking to rebuild its pipeline before crucial cancer drug comes off-patent
International homepage

Post a Comment

0Comments
Post a Comment (0)
Đọc tiếp: